MURDOCK CAPITAL PARTNERS CORP.Apimeds Pharmaceuticals US, Inc. • August 5th, 2024 • Pharmaceutical preparations
Company FiledAugust 5th, 2024 IndustryPursuant to our recent conversations regarding the Think Equity capital raise and IPO Initial Public Offering - for Apimeds Pharmaceuticals US, Inc. (“Apimeds USA”) this letter is to acknowledge and confirm the terms of an advisory and corporate consulting fee agreement (the “consulting agreement”) as follows:
MURDOCK CAPITAL PARTNERS CORP.Apimeds Pharmaceuticals US, Inc. • June 17th, 2024 • Pharmaceutical preparations
Company FiledJune 17th, 2024 IndustryPursuant to our recent conversations regarding the Think Equity capital raise and IPO Initial Public Offering - for Apimeds Pharmaceuticals US, Inc. (“Apimeds USA”) this letter is to acknowledge and confirm the terms of an advisory and corporate consulting fee agreement (the “consulting agreement”) as follows: